i3 Shifts Focus to Growth-Stage African Healthtechs for 3rd Cohort Following US Aid “Stop-work” Directive
Investing in Innovation Africa (i3) has made a pivotal change to its 3rd cohort selection to prioritise the immediate support for 5-7 growth-stage companies building the Future of Pharmacy care in Africa.
This shift comes in response to the U.S. State Department’s “stop-work” directive issued on January 25th, which is expected to disrupt the distribution of essential medicines in Africa’s healthcare supply chains.
i3 notes that the order highlights and intensifies the need for locally-driven, market-creating approaches to health product distribution and service delivery across Africa.
Funded by the Gates Foundation, MSD, Cencora, Endless Foundation, HELP Logistics (a subsidiary of the Kühne Foundation), Sanofi’s Global Health Unit and Chemonics, the i3 program will concentrate its immediate efforts to help innovative growth-stage startups unlock major partnerships to rapidly expand access to patient care.
The selected start-ups will also receive up to $225K in grant funds. i3 aims to expand support to early-stage companies at a later date.
Applications for the i3 3rd cohort are open until February 28th. Apply here:
The selected startups will be announced on April 30th. A virtual Q&A session will be hosted by i3 on February 21st to answer any questions regarding the application process. i3 is coordinated by Salient Advisory and Solina Center for International Development and Research (SCIDaR).
Follow us on WhatsApp, Telegram, Twitter, and Facebook, or subscribe to our weekly newsletter to ensure you don’t miss out on any future updates. Send tips to editorial@techtrendsmedia.co.ke
